Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ: ILMN )

136.69 -2.99 (-2.14%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today
Via Benzinga
CD Genomics Unveils Advanced Mitochondrial DNA Sequencing to Deepen Insights into Genetic Research
Via Press Release Distribution Service
How Is The Market Feeling About Illumina?
Via Benzinga
Santa Claus Rally: 10 S&P 500 Stocks That Consistently Outperform During Year-End Optimism
Stock market gains during Dec. 24-Dec. 31 window, known as Santa Claus rally, averaging 0.85% return in 64 out of 96 years. 2018 saw strongest rally of 6.6%. 
Via Benzinga
Topics Stocks
Exposures US Equities
Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years
Via Benzinga
Traders Fight The Grinch To Save The Santa Rally: 10 S&P 500 Stocks Poised For A Year-End Surge
Holiday celebrations dampened by Fed's hawkish tone, sending shockwaves through markets. Santa Rally hopes crumble before Friday's inflation data, offering a glimmer of hope for a year-end rally. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
CD Genomics Enhances Whole Genome SNP Genotyping Services to Propel Genomic Discoveries
Via Press Release Distribution Service
Super Micro Drops Below 50-Day Average, Faces Nasdaq 100 Removal Just Months After Entry
Super Micro Computer's stock is trading below its 50-day moving average ahead of its removal from the Nasdaq 100 Index on Dec. 23, 2024. The company faces delisting concerns and is seeking to raise... 
Via Benzinga
Nasdaq 100 Shakeup: 3 Stocks That Can Gain
Three stocks have their price targets above current price levels. 
Via Talk Markets
Topics Stocks / Equities
What's Going On With Illumina Stock On Monday?
Illumina exits Nasdaq-100, reports Q3 EPS of $1.14 beating estimates, faces macroeconomic challenges, and lowers 2024 revenue guidance. 
Via Benzinga
What's Going On With Super Micro Computer Shares Monday?
Super Micro is expected to be removed from the Nasdaq 100 Index later this month. 
Via Benzinga
US Stocks To Open Higher Ahead Of Fed's Decision This Week: Analyst Says 'Santa Comes Later In December'
U.S. stock futures were trading higher after the Nasdaq 100 extended its relentless climb last week, nearing the 22,000-point milestone. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Looking Into Illumina's Recent Short Interest
Via Benzinga
If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,600 Today
Via Benzinga
Palantir Stock Is Joining the Nasdaq-100 Index, and Super Micro Computer Is Being Booted: What Investors Should Know
Palantir stock's huge rise this year has earned it a spot on another stock index. 
Via The Motley Fool
GRAIL: Biotech Stock Targeting $100B Cancer Market
GRAIL is a small biotech stock on the rise big time recently. Its innovative technology gives it the opportunity to capitalize on a massive addressable market. 
Via MarketBeat
Topics Death
Exposures Death
MicroStrategy, Palantir, Axon Added To Nasdaq 100: Super Micro Computer, Moderna, Illumina Exit The Index
The much-awaited reconstitution of the Nasdaq 100 index has taken place, resulting in the addition of Bitcoin (CRYPTO: BTC) proxy MicroStrategy Inc. (NASDAQ:MSTR), Palantir Technologies Inc. (NASDAQ: 
Via Benzinga
This D.R. Horton Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Via Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $4,600 Today
Via Benzinga
Decoding 14 Analyst Evaluations For Illumina
Via Benzinga
How Is The Market Feeling About Illumina?
Via Benzinga
Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2
Agreement will expand worldwide access and better position Myriad’s GIS as a potential companion diagnostic across multiple potential tumor types 
From Myriad Genetics, Inc.
Via GlobeNewswire
Smaller Cap Biotechs Are In Season: How Are We Doing?
SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range. 
Via Talk Markets
Wall Street Rallies On Election Day, Palantir Skyrockets, Bitcoin Tops $70,000: What's Driving Markets Tuesday?
Wall Street rallied on Tuesday as improved investor sentiment aligned with millions of Americans casting their votes for the 47th president. 
Via Benzinga
Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years
Via Benzinga
Wall Street Struggles Ahead Of Election Day, Energy Sector Outperforms, Solar Stocks Rise: What's Driving Markets Monday?
The U.S. stock market struggled to gain momentum on Monday as investors remained cautious ahead of Election Day on Tuesday. 
Via Benzinga
Biotech Momentum Trades For The Q4 Rally
The biotech sector made an interim peak in late February followed by an active summer in very choppy trading. 
Via Talk Markets
This Illumina Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Via Benzinga
Biotech Stocks Poised For Another Big Move In Q4
The healthcare sector can be a safe haven if volatility increases. 
Via Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.